Dr. Matthen Mathew, MD

Dr. Mathew practices at Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida.

Dr. Mathew's NPI, 1467741306, was assigned on March 31, 2011. Dr. Mathew graduated from University Of Florida College Of Medicine in 2011. Dr. Mathew holds Florida license 145836.

Dr. Mathew's primary practice is Boca Raton Regional Hospital, at 800 Meadows Rd, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 955-4200.

Dr. Mathew's primary practice is Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida. Dr. Mathew is also affiliated with HCA Florida JFK Hospital. The medical group on file is Eugene M. & Christine E. Lynn Cancer Institute (Lynn Cancer Institute). Dmand AI also links Dr. Mathew to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mathew practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Mathew's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mathew is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mathew's licenses on file in 2 states: Florida and New York.

Dmand AI lists chronic anemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Mathew treats.

CMS data shows 2,797 Medicare services from Dr. Mathew across 8 procedure codes in 2024, for 493 Medicare patients. Medicare paid $155,547 for them.

CMS counts 493 Medicare patients who saw Dr. Mathew in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mathew's median patient age at 76, with 56% women.

In 2024, Dr. Mathew wrote 468 Medicare Part D claims for 152 patients. 57% of them were for generic drugs. CMS names the drug for 272 of them, across 9 drugs with 11 or more claims each, at $1,673,191 in total drug cost. In 2023, CMS named 260 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mathew for performance year 2024, reported individually. Dr. Mathew accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Mathew, published from 2018 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Immunotherapy and Lung Neoplasms. Dr. Mathew's most frequent co-authors are Naiyer A. Rizvi, MD, Catherine Ann Shu and Selim Mehmet Arcasoy, MD.

Dmand AI links Dr. Mathew to 7 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell and Head and Neck Neoplasms. Columbia University sponsors the most, 2.

CMS Open Payments shows 67 general payments to Dr. Mathew from 19 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $320.

Dr. Mathew graduated from University Of Florida College Of Medicine in 2011. Dr. Mathew is a member of ASCO and ASH.

Dr. Mathew is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.